Additionally, studies on youth and adolescent use of GLP-1s, another rapidly growing area of interest, are now possible with this real-world data
In the triple therapy cohort receiving metformin, SGLT2-i, and GLP-1RA, overbasalization declined from 62.5 to 17.5%, and 42.5% of patients were able to stop insulin entirely, reinforcing the additive benefits of combination therapy [44]
The ambivalence of losing weight after bariatric surgery
Its the first nonpeptide small molecule GLP-1 receptor agonist with some very appealing characteristics for patients and prescribers, Ryan said during a presentation
In a Phase 2 trial for T2D, weekly semaglutide was more effective at reducing HbA1c than daily liraglutide (NCT00696657)
statements regarding our plans to offer access to compounded GLP-1s if a provider determines that a compounded product is clinically necessary and the expectation that such customer set will be limited